Salesforce, Inc. (CRM) › Analysis

Salesforce, Inc. (CRM) analysis, February 17, 2026

Published February 17, 2026 · CRM chart, levels and live analysis

Key Updates

Salesforce has declined 3.35% to $183.77 since the February 13 report, reversing the prior session's 5.00% recovery and falling back below the $190 psychological level. The stock continues to establish new multi-year lows with YTD losses now at -30.63%, significantly underperforming broader market indices. Two significant corporate developments emerged: the $5.6 billion U.S. Army contract announced January 27 has failed to provide price support, while the strategic decision to scale back Heroku enterprise subscriptions signals portfolio rationalization focused on AI-native solutions. The persistent downward pressure reflects ongoing sector concerns about AI disruption to traditional SaaS business models.

Current Trend

Salesforce is in a severe downtrend with YTD losses of -30.63%, establishing consecutive multi-year lows. The stock has declined 24.20% over six months and 19.08% over one month, demonstrating accelerating negative momentum. Price action shows consistent failure to hold support levels: the $190 psychological level was briefly reclaimed on February 13 but immediately lost, and the current $183.77 level represents a fresh bottom. The 1-day decline of -3.14% and 5-day decline of -5.29% indicate no stabilization. Trading volume and volatility remain elevated, with the stock underperforming both technology sector peers and broader market indices by substantial margins.

Investment Thesis

The investment thesis centers on Salesforce's transition from traditional SaaS provider to AI-native enterprise platform, balanced against structural concerns about AI-driven margin compression. The $5.6 billion U.S. Army contract validates government sector positioning and provides long-term revenue visibility through 2036, though as an IDIQ ceiling rather than guaranteed revenue. Strategic portfolio rationalization, evidenced by Heroku scale-back, demonstrates capital allocation discipline and focus on higher-margin AI solutions like Agent Builder and Missionforce. However, the thesis faces headwinds from sector-wide concerns that advanced AI may commoditize traditional CRM functionality, reducing pricing power and threatening the high-margin SaaS model. The company's ability to monetize AI innovation while defending core CRM market share remains the critical determinant of valuation recovery.

Thesis Status

The investment thesis is under pressure but showing early signs of strategic repositioning. The $5.6 billion Army contract announced January 27 confirms government sector traction and validates the Missionforce National Security offering, though market reaction has been negative, suggesting investors view this as insufficient to offset core business concerns. The Heroku scale-back announced February 6 represents necessary portfolio pruning to redirect resources toward AI-native solutions, but also highlights competitive pressure from hyperscale cloud providers. The emergence of AI-native competitors like Aurasell, which raised $30 million to build workflow automation layers on top of Salesforce, presents both ecosystem validation and margin compression risk. The -30.63% YTD decline indicates the market is pricing in significant probability of structural business model disruption, requiring management to demonstrate AI monetization success in upcoming earnings to restore confidence.

Key Drivers

The primary near-term driver is the upcoming Q4 earnings call, where management must address both the financial contribution framework for the $5.6 billion Army contract and strategic rationale for the Heroku enterprise subscription discontinuation. Sector-wide AI disruption concerns continue to pressure valuations, with investors questioning whether traditional SaaS providers can maintain pricing power as AI agents automate workflows previously requiring software subscriptions. The competitive landscape is intensifying, with Aurasell's $30 million funding demonstrating venture capital appetite for AI-native alternatives that layer on top of incumbent CRMs. Insider selling activity, including Director Neelie Kroes' divestment of shares worth $929,259, contributes to negative sentiment. The broader market environment, with 91 S&P 500 constituents experiencing consecutive losing streaks, suggests macro headwinds beyond company-specific factors.

Technical Analysis

Salesforce is in a confirmed downtrend across all timeframes, with the current price of $183.77 representing a new multi-year low. The stock failed to hold the February 13 recovery above $190, immediately reversing and breaking down further. Key resistance levels are now established at $190 (psychological level and previous support), $200 (round number resistance), and $210 (approximate 6-month breakdown level). Support levels are increasingly unclear given the persistent new lows, with $180 representing the next psychological level and potential capitulation zone. The price action shows consistent lower highs and lower lows, with each recovery attempt failing quickly. Volume patterns suggest sustained selling pressure rather than panic capitulation, indicating fundamental reassessment rather than technical oversold conditions. The -30.63% YTD decline has pushed the stock into deeply oversold territory by historical standards, though momentum indicators suggest no immediate reversal catalyst.

Bull Case

Bear Case

Get a message when the CRM picture changes — the agent team watches the levels and the news for you.Create a free account

More CRM analyses